Parnell Pharmaceuticals Holdings Ltd. Announces Consolidated Earnings Results for the Year Ended December 31, 2015; Provides Revenue Guidance for the Year 2016
Parnell Pharmaceuticals Holdings Ltd. announced consolidated earnings results for the year ended December 31, 2015. For the period, the company reported revenue of AUD 13,169,753 against AUD 8,361,058 a year ago. Loss before income tax was AUD 13,735,419 against AUD 11,362,506 a year ago. Loss for the year was AUD 13,737,532 against AUD 14,345,360 a year ago.
For the year 2016, the company expects total group revenue to grow 50% - 70% to AUD 20 million to AUD 22 million.